Genetic determinants of bone mineral density loss in Aromatase inhibitors treatment

被引：0

作者：

Rodriguez-Sanz, Maria ^{[1
]}

Prieto-alhambra, Daniel ^{[2
]}

Servitja-Tormo, Sonia ^{[3
]}

Torres-Del-Pliego, Elisa ^{[4
]}

Mellibovsky, Leonardo ^{[4
]}

Garrigos, Laia ^{[3
]}

Garcia-Giralt, Natalia ^{[1
]}

Diez-Perez, Adolfo ^{[5
]}

Tusquets, Ignacio ^{[3
]}

Nogues, Xavier ^{[6
]}

机构：

[1] IMIM, Madrid, Spain

[2] Univ Oxford, Oxford OX1 2JD, England

[3] Parc Salut Mar, Dept Med Oncol, Barcelona, Spain

[4] Inst Salud Carlos III FEDER, URFOA IMIM, Red Temat Invest Cooperat Envejecimiento & Fragil, Barcelona, Spain

[5] Autonomous Univ Barcelona, E-08193 Barcelona, Spain

[6] Inst Municipal Invest Med, Madrid, Spain

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2013年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SU0434

引用

页数：3

共 50 条

[31] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
不详
Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
[32] Bone Mineral Density Screening Among Women with a History of Breast Cancer Treated with Aromatase Inhibitors
Spangler, Leslie
Yu, Onchee
Loggers, Elizabeth
Boudreau, Denise M.
JOURNAL OF WOMENS HEALTH, 2013, 22 (02) : 132 - 140
[33] Bone mineral density screening and monitoring in early breast cancer patients treated with aromatase inhibitors
Gilani, S.
Ikram, N.
ANNALS OF ONCOLOGY, 2022, 33 : S227 - S227
[34] Bone mineral density in patients using aromatase inhibitors: a clinical, nutritional, and quality of life assessment
de Souza, Alessandra Figueiredo
Barra, Samila Gonsalves
Rocha, Amanda Leal
Bemquerer, Larissa Marques
Oliveira, Sicilia Rezende
Carvalho, Larissa Nayane
Amaral, Tania Mara Pimenta
Brasileiro, Claudia Borges
Costa, Fernando Oliveira
Souza, Leandro Napier
Camargos, Bruno Muzzi
de Lima, Enaldo Melo
Ferreira, Adaliene Versiani Matos
Heredia, Joyce Elisa
de Oliveira, Marina Chaves
Macari, Soraia
Abreu, Lucas Guimaraes
Mesquita, Ricardo Alves
Silva, Tarcilia Aparecida
BRAZILIAN ORAL RESEARCH, 2025, 39
[35] Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors
Charlson, John
Smith, Elizabeth C.
Smallwood, Alicia J.
Laud, Purushottam W.
Neuner, Joan M.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07): : 875 - 880
[36] Bone mineral density and bone loss over time in men with chronic heart failure, and their determinants
Jankowska, Ewa A.
Cwynar, Aldona
Jakubaszko, Justyna
Majda, Jacek
Wegrzynowska, Kinga
Banasiak, Waldemar
Ponikowski, Piotr
CIRCULATION, 2006, 114 (18) : 805 - 805
[37] Challenges in Preventing Bone Loss Induced by Aromatase Inhibitors
Rachner, Tilman D.
Gobel, Andy
Jaschke, Nikolai P.
Hofbauer, Lorenz C.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10): : 1 - 12
[38] The Effect of Exercise on Body Composition and Bone Mineral Density in Breast Cancer Survivors Taking Aromatase Inhibitors
Thomas, Gwendolyn A.
Cartmel, Brenda
Harrigan, Maura
Fiellin, Martha
Capozza, Scott
Zhou, Yang
Ercolano, Elizabeth
Gross, Cary P.
Hershman, Dawn
Ligibel, Jennifer
Schmitz, Kathryn
Li, Fang-Yong
Sanft, Tara
Irwin, Melinda L.
OBESITY, 2017, 25 (02) : 346 - 351
[39] Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients
Berruti, Alfredo
Tucci, Marcello
Mosca, Alessandra
Vana, Federica
Ardine, Mara
Dogliotti, Luigi
Angeli, Alberto
Bertoldo, Francesco
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1455 - 1456
[40] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
Katsuhiko Nakatsukasa
Hiroshi Koyama
Yoshimi Ouchi
Kouichi Sakaguchi
Yoshifumi Fujita
Takayuki Matsuda
Makoto Kato
Eiichi Konishi
Tetsuya Taguchi
Journal of Bone and Mineral Metabolism, 2019, 37 : 301 - 306

← 1 2 3 4 5 →